MAPT and early-onset autosomal dominant Alzheimer disease: <h4>Introduction</h4>Phosphorylated tau-217 (p-tau 217) is widely used as a plasma-based biomarker for Alzheimer's Disease (AD) detection, demonstrating superior accuracy for detecting brain amyloid pathology.